Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates ... of drug candidates, and their medical use, which is to treat epilepsy and seizures.
Aqilion finalizes the eosinophilic esophagitis specific formulation pharmacokinetic study with the drug candidate AQ280 ... esophagitis with the same mechanism of action as Aqilion’s drug candidate AQ280.
By targeting a previously unexploited metabolic pathway essential for bacterial survival, the drug candidate may offer the potential to develop safer, shorter and more effective treatment regimens.
‘DIADEME’ project awarded €6.5 million in government funding via France 2030, enabling Ciloa to advance development of its bio-drug APN-sEV (Adiponectin associated with exosomes), the world’s only ...
In their search for a GSK3β inhibitor, Miles and his colleagues came across a drug candidate called tideglusib, which is being used in clinical trials for brain disorders like Alzheimer's disease.
Drug candidate is one of several oncology assets approaching or in clinical development, discovered through Oxford BioTherapeutics’ proprietary OGAP®-Verify discovery platform ... .
The Company's pipeline includes oral drug candidates designed to address significant unmet medical needs in areas such as anxiety, cognitive decline, neuropathic pain, obesity, and addiction.